These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7499099

  • 1. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S, Kroll S, Char DH, Frigillana H.
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [Abstract] [Full Text] [Related]

  • 2. Cell cycling and prognosis in uveal melanoma.
    Lattman J, Kroll S, Char DH, Ghazvini S, Frigillana H, O'Brien JM, Elbakri HR.
    Clin Cancer Res; 1995 Jan; 1(1):41-7. PubMed ID: 9815885
    [Abstract] [Full Text] [Related]

  • 3. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S, Oskarsson M, Spångberg B.
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical detection of proliferative cells.
    Mokrý J, Nĕmecek S.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995 Jun; 38(3):107-13. PubMed ID: 8685626
    [Abstract] [Full Text] [Related]

  • 5. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ.
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [Abstract] [Full Text] [Related]

  • 6. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
    Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ.
    J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
    [Abstract] [Full Text] [Related]

  • 8. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
    Nakamura T, Tabuchi Y, Nakae S, Ohno M, Saitoh Y.
    Cancer; 1996 Apr 15; 77(8 Suppl):1741-6. PubMed ID: 8608572
    [Abstract] [Full Text] [Related]

  • 9. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
    Okuno Y, Nishimura Y, Kashu I, Ono K, Hiraoka M.
    Br J Cancer; 1999 May 15; 80(3-4):387-95. PubMed ID: 10408843
    [Abstract] [Full Text] [Related]

  • 10. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
    Proniewska-Skretek E, Dziecioł J, Zalewska R, Mariak Z.
    Rocz Akad Med Bialymst; 2004 May 15; 49 Suppl 1():79-81. PubMed ID: 15638382
    [Abstract] [Full Text] [Related]

  • 11. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.
    Oncol Rep; 2008 Jan 15; 19(1):49-56. PubMed ID: 18097575
    [Abstract] [Full Text] [Related]

  • 12. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM, Kallioniemi OP, Isola JJ.
    Am J Pathol; 1993 Apr 15; 142(4):1081-9. PubMed ID: 7682759
    [Abstract] [Full Text] [Related]

  • 13. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
    Lee KS, Yang WI.
    Yonsei Med J; 1992 Sep 15; 33(3):265-71. PubMed ID: 1363339
    [Abstract] [Full Text] [Related]

  • 14. [A study on tongue cancer cell labeling using bromodeoxyuridine (BrdU) incorporation in vitro].
    Li X, Zhao Q, He R, Zhou X, Chen W.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct 15; 19(5):278-80. PubMed ID: 12539478
    [Abstract] [Full Text] [Related]

  • 15. [Measurement of PCNA labeling index in astrocytic tumors].
    Beppu T, Arai H, Kanaya H, Sasaki K.
    No Shinkei Geka; 1992 Dec 15; 20(12):1255-9. PubMed ID: 1362456
    [Abstract] [Full Text] [Related]

  • 16. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M.
    Fukuoka Igaku Zasshi; 1999 Jan 15; 90(1):6-13. PubMed ID: 10087668
    [Abstract] [Full Text] [Related]

  • 17. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA.
    Exp Hematol; 1996 Jun 15; 24(7):807-15. PubMed ID: 8647231
    [Abstract] [Full Text] [Related]

  • 18. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Jun 15; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 19. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
    Kram A, Domagała W.
    Pol J Pathol; 1996 Jun 15; 47(4):183-7. PubMed ID: 9097710
    [Abstract] [Full Text] [Related]

  • 20. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
    Lyshchik A, Higashi T, Hara T, Nakamoto Y, Fujimoto K, Doi R, Imamura M, Saga T, Togashi K.
    Cancer Invest; 2007 Jun 15; 25(3):154-62. PubMed ID: 17530485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.